Lansoprazole
( DrugBank: Lansoprazole / KEGG DRUG: Lansoprazole )
4 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
71 | Idiopathic osteonecrosis of the femoral head | 1 |
85 | Idiopathic interstitial pneumonia | 3 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
166 | Pseudoxanthoma elasticum | 2 |
299 | Cystic fibrosis | 1 |
71. Idiopathic osteonecrosis of the femoral head
Clinical trials : 2 / Drugs : 3 - (DrugBank : 3) / Drug target genes : 3 - Drug target pathways : 7
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
85. Idiopathic interstitial pneumonia
Clinical trials : 723 / Drugs : 411 - (DrugBank : 126) / Drug target genes : 104 - Drug target pathways : 212
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
166. Pseudoxanthoma elasticum
Clinical trials : 19 / Drugs : 21 - (DrugBank : 7) / Drug target genes : 5 - Drug target pathways : 26
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
299. Cystic fibrosis
Clinical trials : 1,826 / Drugs : 1,271 - (DrugBank : 246) / Drug target genes : 118 - Drug target pathways : 180
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|